BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2006
View Archived Issues
YM-201627 presented as a new agent for solid tumors
Read More
Preclinical experiments support use of desvenlafaxine for menopause symptoms
Read More
Increlex stability, structural features detailed
Read More
GTx reports on novel nonsteroidal selective androgen receptor modulators
Read More
Cardioprotective effects of a new exendin-4 analogue
Read More
Iplex shows promise in severe insulin resistance syndromes
Read More
Bremelanotide affects desire and arousal in female sexual arousal disorder patients
Read More
S-2367 shows efficacy in maintaining and continuing weight loss in obese subjects
Read More
Japanese submission for minodronic acid hydrate in osteoporosis
Read More
Pivotal study begins for HuMax-CD20 in NHL
Read More
Takeda licenses rights to Galaxy's anti-HGF antibody
Read More
Grant for study of alagebrium effects on renal function in diabetes patients
Read More
Antigenics and GSK expand license and supply agreements for QS-21 adjuvant
Read More
Approvable letter for Cellegesic
Read More
Pivotal study of Mozobil completes enrollment
Read More
PRX-08066 relaxes pulmonary arteries without affecting systemic blood pressure in rodents
Read More
Astemizole shows antimalarial potential in preclinical studies
Read More
JNJ-1250132: A unique progesterone receptor modulator
Read More
Hemopure submitted for U.K. approval
Read More
Avandamet approved for initial treatment of type 2 diabetes
Read More
FDA approves Emend for prevention of postoperative nausea and vomiting
Read More
Recent patents report novel vanilloid VR1 receptor antagonists
Read More
Recent patents disclose novel agents for HCV infection
Read More
Schizophrenia, depression, etc. targets of newly patented compounds
Read More